James Sherley is a biological engineer and the founder of Asymmetrex, an adult stem cell research center.
From 1991 to 1998 he was associate member, division of medical science, molecular oncology group, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
[10] Frank L. Douglas, then the director of the Center for Biomedical Innovation, resigned from the university as a result of the handling of the case.
"Despite similar misinformation to the contrary, adult stem cell research is a viable and vibrant path to new medical therapies.
[13] He fought to ban the NIH from funding any research related to embryonic stem cells, and claimed that the decision of the federal government to pay for research on embryonic stem cells was "essentially robbing him of grant money by increasing the competition for funding".
[14] After three years of legal effort, the supreme court refused to overturn a lower judge's ruling against Sherley, allowing research to proceed.